CAPASTAT SULFATE (Akorn)
Welcome to the PulseAid listing for the CAPASTAT SULFATE drug offered from Akorn. This Antimycobacterial [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Akorn |
| NON-PROPRIETARY NAME: | Capreomycin |
| SUBSTANCE NAME: | CAPREOMYCIN SULFATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Antimycobacterial [EPC] |
| ROUTE: | INTRAMUSCULAR; INTRAVENOUS |
| DOSAGE FORM: | INJECTION, POWDER, FOR SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2009-08-01 |
| END MARKETING DATE: | 0000-00-00 |
CAPASTAT SULFATE HUMAN PRESCRIPTION DRUG Details:
| Item Description | CAPASTAT SULFATE from Akorn |
| LABELER NAME: | Akorn |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 1(g/1) |
| START MARKETING DATE: | 2009-08-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 17478-080_2b14f1a3-f8d6-45e8-a31a-89dc25d5c7f8 |
| PRODUCT NDC: | 17478-080 |
| APPLICATION NUMBER: | NDA050095 |
Other CAPREOMYCIN SULFATE Pharmaceutical Manufacturers / Labelers:
